MIRM
Mirum Pharmaceuticals Inc

1,598
Mkt Cap
$3.76B
Volume
18,563.00
52W High
$78.54
52W Low
$36.88
PE Ratio
-84.86
MIRM Fundamentals
Price
$73.02
Prev Close
$73.13
Open
$73.54
50D MA
$71.95
Beta
0.73
Avg. Volume
578,376.83
EPS (Annual)
-$1.85
P/B
12.85
Rev/Employee
$1.05M
Loading...
Loading...
News
all
press releases
Intech Investment Management LLC Sells 6,709 Shares of Mirum Pharmaceuticals, Inc. $MIRM
Intech Investment Management LLC reduced its stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 24.4% during the 2nd quarter, according to its most recent 13F filing with the...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Geode Capital Management LLC Grows Position in Mirum Pharmaceuticals, Inc. $MIRM
Geode Capital Management LLC grew its holdings in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 6.8% in the second quarter, according to the company in its most recent 13F...
MarketBeat·2d ago
News Placeholder
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a biopharmaceutical company focused on the identification, acquisition, development and commercialization of novel therapies for debilitating rare and...
Business Wire·3d ago
News Placeholder
Los Angeles Capital Management LLC Buys New Position in Mirum Pharmaceuticals, Inc. $MIRM
Los Angeles Capital Management LLC purchased a new stake in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) in the second quarter, according to its most recent filing with the Securities...
MarketBeat·11d ago
News Placeholder
Bank of New York Mellon Corp Boosts Stock Position in Mirum Pharmaceuticals, Inc. $MIRM
Bank of New York Mellon Corp increased its holdings in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 101.1% during the second quarter, according to its most recent filing with...
MarketBeat·12d ago
News Placeholder
Candriam S.C.A. Reduces Holdings in Mirum Pharmaceuticals, Inc. $MIRM
Candriam S.C.A. decreased its position in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) by 2.6% during the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·13d ago
News Placeholder
Penserra Capital Management LLC Takes Position in Mirum Pharmaceuticals, Inc. $MIRM
Penserra Capital Management LLC bought a new position in shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) during the second quarter, according to its most recent disclosure with the...
MarketBeat·14d ago
News Placeholder
Nan Fung Trinity HK Ltd. Acquires Shares of 146,765 Mirum Pharmaceuticals, Inc. $MIRM
Nan Fung Trinity HK Ltd. acquired a new position in Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) in the second quarter, according to the company in its most recent filing with the...
MarketBeat·15d ago
News Placeholder
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on November 10, 2025, the Compensation Committee of Mirums Board of Directors granted inducement awards consisting of non-qualified...
Business Wire·18d ago
News Placeholder
FY2027 Earnings Estimate for MIRM Issued By Leerink Partnrs
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM - Free Report) - Investment analysts at Leerink Partnrs raised their FY2027 earnings estimates for Mirum Pharmaceuticals in a research report issued to...
MarketBeat·21d ago

Latest MIRM News

View

Advertisement|Remove ads.

Advertisement|Remove ads.